Patents & Licensing

Focusing on the future growth of Vivera’s various divisions, the Company has filed several patent applications for new medical devices, technologies, and pharmaceutical treatments utilizing the TABMELT® platform.

Behind the development of each product are years of expertise, research, design, and development focused on bringing the best solutions to the market for patients and their providers.

Vivera has begun laying the groundwork for clinical research trials for a variety of indications, via the Investigational New Drug (IND) and/or New Drug Application (NDA) pathways, to gain FDA approval and globally commercialize its finished pharmaceutical products.

BioSciences Patents

TABMELT®

CountryCompoundPatent Status
United StatesVVRA – TM 001: Cardiovascular drugApplication Filed
United StatesVVRA – TM 002: CNS drugApplication Filed
United StatesVVRA – TM 003: CNS drugApplication Filed
United StatesVVRA – TM 004: CNS combinationApplication Filed
United StatesVVRA – TM 005: CNS drugApplication Filed
United StatesPTNR – TM 006: CNS drugApplication Filed
United StatesPTNR – TM 007: CNS drugApplication Filed
United StatesVVRA – TM 008: CNS drugFiling Application

ZICOH®

Country Title Patent Status
United States SECURE SMART DOSING SYSTEM WITH AUTOMATED DELIVERY, MEASUREMENT, AND MANAGEMENT Granted, 2021
United States SMART INHALER DEVICE WITH AUTOMATED DOSE DELIVERY, MEASUREMENT, AND MANAGEMENT Granted, 2021

Licensed Patents

Country Title Patent Status
Australia All Natural, Non-Toxic Sublingual Drug Delivery Systems Granted, 2016
Canada All Natural, Non-Toxic Sublingual Drug Delivery Systems Granted, 2018
Great Britain All Natural, Non-Toxic Sublingual Drug Delivery Systems Granted, 2018
Russia All Natural, Non-Toxic Sublingual Drug Delivery Systems Granted, 2021
Israel All Natural, Non-Toxic Sublingual Drug Delivery Systems Application Filed
Japan All Natural, Non-Toxic Sublingual Drug Delivery Systems Application Filed
Mexico All Natural, Non-Toxic Sublingual Drug Delivery Systems Application Filed
United States All Natural, Non-Toxic Sublingual Drug Delivery Systems Application Filed

Medical Device Patents

Country Title Patent Status
United States NEUROSCIENCES MEDICAL DEVICE AND SOFTWARE Filing Application
United States SELF-CONTAINED, PORTABLE, SANITIZATION DEVICE AND TELEMEDICINE STATION Application Filed
United States PHASED INFECTION TESTING METHOD AND APPARATUS Application Filed
United States INFECTION TESTING METHOD AND APPARATUS Application Filed

Indication Schedule